Justin Gregg, MD, on the Use of the Mediterranean Diet in Men With Localized Prostate Cancer
The assistant professor of Urology at The University of Texas MD Anderson Cancer Center spoke about the results of a study which evaluated the use of the Mediterranean diet in men with localized prostate cancer on active surveillance.
The Mediterranean diet was revealed to be associated with a lower risk of Gleason Grade group progression among men with localized prostate cancer on active surveillance, according to a study (NCT00490763) published in Cancer.
These findings are consistent with previous reports of the Mediterranean diet, resulting in reductions in cancer morbidity and mortality. However, follow-up in larger studies of men enrolled on active surveillance are still necessary to verify patient- and cancer-specific effects of adherence to the Mediterranean diet in men with early-stage prostate cancer.
In an interview with CancerNetwork®, Justin Gregg, MD, assistant professor of Urology at The University of Texas MD Anderson Cancer Center as well as lead author of the study, discussed these findings and what led he and his colleagues to conduct this research.
This segment comes from the CancerNetwork® portion of the MJH Life Sciences™ Medical World News®, airing daily on all MJH Life Sciences channels.
Reference:
Gregg JR, Zhang X, Chapin BF, et al. Adherence to the Mediterranean diet and grade group progression in localized prostate cancer: An active surveillance cohort. Cancer. Published online January 7, 2020. doi:10.1002/cncr.33182
FDA Expands Indication for Illuccix for PSMA Radioligand Selection in Prostate Cancer
